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INTRODUCTION
Phytomedicine is increasingly receiving attention from both the public and healthcare professionals. [1] However, possible interaction(s) between herbal preparations and other concomitantly administered synthetic medications may cause very serious medical problems. [2] [3] [4] [5] Pharmacokinetic interactions between medicinally active plants and other synthetic drugs may cause a change in liberation, absorption, distribution, metabolism, excretion, or toxicity of a respective drug. Apart from that, plant extracts may cause many pharmacodynamic interactions with the receptors and enzymes leading to enhanced or attenuated pharmacological action of therapeutics, which might cause unwanted effects. [6, 7] Therefore, understanding the ability of medicinal plants to modulate the metabolizing enzymes is really crucial for a responsible treatment of patients. [8] The cytochrome P450 (CYP) enzymes are the main players in Phase I metabolism and also involved in the oxidation and elimination of a wide array of xenobiotics (such as drugs and toxins). Drug metabolism involves around 15 different CYP isoforms in which CYP 1A2, 2C9, 2C19, 2D6, 2E1, and 3A4 are the most abundant. [9] CYP3A4 acts on lipophilic substrates and metabolizes about 50% of the drugs in the liver [10] whereas CYP2D6 exhibits a preference for positively charged molecules, usually containing a basic nitrogen. On the other hand, CYP2C9 metabolizes weakly anionic molecules, while CYP1A2 acts on polyaromatic hydrocarbons, and CYP2E1 metabolizes small relatively soluble organic compounds. [11] CYP3A4 is the most abundant isoform of the human CYP system accounting for approximately 28% of the whole enzyme system. [12, 13] The CYP3A4 enzyme usually introduces a hydroxyl or epoxy group to many lipophilic substrates. Then, the hydroxylated xenobiotics become conjugated with glucuronic acid, sulfate, or amino acids. In turn, they become eliminated via the kidney and urine. [14] A number of therapeutic agents, including natural products, are the main substrates of CYP3A4. Among them, quinidine, vinblastine, ergotamine, berberine, and colchicine are the most known [15] while nifedipine and diazepam figure as common synthetic substrates. [16] Furthermore, CYP3A4 activity can be inhibited by many plant extracts. [17, 18] Grapefruit with the furanocoumarin derivatives and flavonoids [19] and kava-kava with its kavalactones [20] are prominent examples for herbal drugs that can cause clinically important modulation in CYP3A4 activity. On the other hand, prolonged use of Hypericum extracts, containing hypericin, results in an induction of the enzyme activity. [21] [22] [23] Because the plants used in Traditional Chinese Medicine (TCM) are diverse, our knowledge about the interactions between these herbal drugs and the CYP system is rather limited. [1, 24] Therefore, in this communication, we investigated the potential inhibition of CYP3A4 by 57 widely used TCM plants to explore the relevance of this activity with regard to adverse effects. Moreover, statistical analysis using principal component analysis (PCA) was applied to correlate the inhibitory activity with the main compounds present in the plant extracts. Additionally, molecular docking was carried out with 38 major secondary metabolites found in the bioactive plant extracts to validate the inhibition results.
MATERIALS AND METHODS

Plant materials
TCM plants were purchased from Chinese markets. Their identity was ascertained in our laboratory through DNA barcoding technique. [25] Voucher specimens are stored at the Department of Biology, Institute of Pharmacy and Molecular Biotechnology, Heidelberg University under the accession numbers P6835-P6919.
Preparation of the plant extracts
One hundred gram of dried plants were grounded to a fine powder. Plant powders were refluxed with 1 L of either methanol or deionized, distilled water (analytical grade) for 4 h. The methanol (MeOH) extracts were dried over anhydrous Na 2 SO 4 and evaporated till dryness under vacuum at 45°C, whereas the water (H 2 O) extracts were evaporated directly under the same conditions until dryness. Then, they were lyophilized overnight to ensure optimum dryness. The extracts are kept in tight sealed vials at -20°C away from light until use.
CYP3A4 activity
The CYP3A4 assay kit (P450-Glo TM , Promega®, Mannheim, Germany) was used to determine the potential inhibition of recombinant human CYP3A4 enzyme by different plant extracts according to the manufacturer protocol. [26] Briefly, the samples were prepared using dimethyl sulfoxide (DMSO) to give final concentrations of 100, 200, and 500, or 1000 µg/mL where DMSO did not exceed 1% of the solutions. Equal volumes (12.5 µL) of each tested sample and the reaction mixture containing 5 mM luciferin-6'-benzyl ether (CYP3A4 specific substrate) in 100 mM phosphate buffer (pH 7.4) and the enzyme (1 pmol/µL) were incubated at 25°C for 10 min. Then, 25 µL of NADPH regeneration system containing 26 mM NADP+, 66 mM glucose-6-phosphate, 66 mM MgCl 2 , and 40 U/mL glucose-6-phosphate dehydrogenase in 5 mM citrate buffer (pH 5.5) in 1 M phosphate buffer was added and left for 30 min to activate the enzyme. A luciferin detecting reagent (50 µL) was added to stop the CYP3A4 enzyme activity. The luminescence was detected after 20 min using a Tecan TM SafireII Reader (Tecan TM , Crailsheim, Germany). The effects of different extracts were evaluated in triplicate relative to blank control containing 1% DMSO. Ketoconazole (10 µM) was used as a positive control.
Molecular modeling studies
In silico molecular modeling of the major compounds present in the bioactive extracts was carried out using Discovery Studio 2.5 (Accelrys® Inc., San Diego, CA, USA) using C-Docker protocol applying both pH-based as well as rule based ionization methods to simulate the physiological conditions and to evaluate the influence of ionization of various ionizable groups on the behavioral interaction of the secondary metabolites at the active site of the enzyme. The x-ray crystal structure of CYP3A4 (PDB ID 4NY4, 2.95 Å) co-crystalized with its lead
pyrimidine-6-amine), was obtained from the protein data bank (www. pdb.org). The standard protein preparation protocol was applied to construct the structure of the enzymes. This was briefly done by the addition of hydrogen atoms to the enzyme and cleansing of all undesirable interactions. Then, the binding site was determined by detection of the binding mode of bioactive conformation of the lead compound (L) with CYP3A4. [27] The structures of the selected compounds were docked inside the binding site after applying CHARMm as the force field and the binding energies and modes for the selected docking poses were determined as described before. [28] Statistical analysis Data were presented as means ± mean standard deviation. One-way analysis of variance (ANOVA) with Tukey's post hoc test was used to identify statistically significant (P < 0.05) differences between the groups. Analyses were performed with Prism 5.0 software (Graph Pad®, San Diego, USA). Chemometric analysis of the data was performed using unsupervised pattern recognition techniques applying PCA, where a matrix of the total number of samples (57 samples) multiplied by the different tested doses for both water and alcoholic extracts (six variables) was constructed. PCA was performed by Unscrambler® 9.7 (CAMO, AS, Norway).
RESULTS
All TCM extracts inhibited CYP3A4 activity to some degree [ Table 1 ]. Generally, the H 2 O extracts were more potent than the MeOH extracts, and their corresponding activities were positively correlated as shown in Figure 1 a-c. Therefore, multivariate analysis was applied to statistically evaluate the significance of inhibition of the CYP enzyme. Moreover, clustering the plants samples based on their activity and their chemical profiling was established. The PCA score plot [ Figure 2 ] resulted in two orthogonal PCs, which explained about 89% of the variance in 180-dimensional space using only the first two components (the first PC accounts for 65% of the total variance followed by the second PC with 24%). PCA score plot classified the samples into five main clusters according to their similarity of cytochrome P450 inhibition utilizing Pharmacognosy Magazine, Volume 13, Issue 50, April-June, 2017 [38] Andrographis paniculata (Acanthaceae) P6838/ Herb Diterpenolactones: andrographolide, 14-deoxy-11-dehydroandrographolide, 14-deoxy-11-oxoandrographolide, 5-hydroxy-7,8,2' ,3'-tetramethoxyflavone, neoandrographolide, paniculide-A, paniculide-B and paniculide-C. [39, 40] Arctium lappa (Asteraceae) P6839/Seeds Lignans: Lappaol F, diarctigenin and arctigenin [41] Areca catechu (Arecaceae) P6840/ Seeds Alkaloids: arecoline, arecaidine, arecolidine, guvacine, guvacoline, isoguvacine, norarecaidine and norarecoline. [42] Artemisia annua (Asteraceae) P6841/ Herb Sesquiterpene lactone: Artemisinin, deoxyartemisinin, artemisinic acid, arteannuin-B, stigmasterol, friedelin, friedelan-3 beta-ol, artemetin, and quercetagetin 6,7,3' ,4'-tetramethyl ether. [43, 44] Artemisia capillaris (Asteraceae) P6842/ Herb Flavone: 5, 2' ,4'-trihydroxy 6,7,5'-trimethoxyflavone.
Phenylalkynes: capillaridins A-H, capillin, capillene and O-methoxycapillene, 6'-O-caffeoyl-phydroxyacetophenone-4-O-β-D-glucopyranoside and 6-amino-9-[1-(3,4-dihydroxyphenyl) ethyl]-9H-purine.
Coumarins: coumarin, scopoletin [45, 46] Belamcanda chinensis (Iridaceae) P6843/Rhizome Phenolic compounds: Belalloside A, belalloside B, belamphenone, resveratrol, iriflophenone, irisflorentin, tectorigenin, irilin D, tectoridin, iristectorin A, iristectorin B, hispiduloside, androsin, irigenin, iridin, and jaceoside, [47] Bupleurum marginatum (Apiaceae) P6845/ Herb Flavonoids and steroids: Rutin, isoquercetrin, isorhamnetin, quercetin, β-sitosterol, α-spinasterol, daucosterol, α-spinasterol glucoside. [34] Cassia tora (Fabaceae) P6847/ Seeds Anthraquinones and anthraquinones derivatives: Chrysophanol, naphtho-α-pyrone-toralactune, physcion, rubrofusarin, chrysophonic acid -9 -anthrone, dianthrone glycosides (sennoside A, B). [48, 49] Centella asiatica (Apiaceae) P6849/ Herb Triterpenes: madecassic acid, brahmic acid and asiatic acid.
Triterpenoid ether glycosides: madecassoside, asiaticoside, brahmoside and brahminoside. [50] Centipeda minima (Asteraceae) P6850/ Herb Sesquiterpene lactones: 6-O-methylacrylylplenolin, 6-O-isobutyroylplenolin, and 6-O-angeloylplenolin, senecioylplenolin, aurantiamide acetate, tetrahydrohelenalin.
Flavonoids: quercetin-3-methyl ether, quercetin-3,3'-dimethyl-ether, quercetin-3,7,3'-trimethyl-ether, quercetin-3,7,3' ,4'-tetramethyl-ether and α-cyperone. [51] Chrysanthemum indicum (Asteraceae)
P6851/ Flowers Flavonoids: (2S)-eriodictyol 7-O-β -D-glucopyranosiduronic acid, (2R)-eriodictyol 7-O-β -D-glucopyranosiduronic acid, (2S,3S)-1-phenyl-2,3-butanediol 3-O-β-D-glucopyranoside, apigenin 7-O-β -D-glucopyranoside, diosmetin 7-O-β -D-glucopyranoside, quercetin 3,7-di-O-β-Dglucopyranoside,, luteolin 7-O-β -D-glucopyranoside, luteolin 7-O-β-D-glucopyranosiduronic acid, acacetin 7-O-α-L-rhamnopyranosyl)-β-D-glucopyranoside and eupatilin.
[52]
Chrysanthemum morifolium (Asteraceae) P6852/ Flowers Triterpene alcohol: pentacyclic triterpene diols and triols: faradiol, heliantriol B, heliantriol C, 22-alpha-methoxyfaradiol, arnidiol, and faradiol alpha-epoxide, maniladiol, erythrodiol, longispinogenin, coflodiol, heliantriol A, brein and uvaol, calenduladiol and heliantriol B.
Phenolic compounds: luteolin-7-O-β-glucoside, quercitrin. chlorogenic acid, 3,5-O-caffeoylquinic acid, galuteolin, acacetin-7-O-β-d-glucopyranoside, acacetin-7-O-α-l-rhamopyranoside, eriodictyol, eriodictyol 7-O-glucuronide, arabinogalactan, vitexin-2-O-rhamnoside, quercetin-3-galactoside, luteolin-7-O-β-glucuronide, diosmetin, acacetin, and apigenin. Sesquiterpenes: chrysanthediol A, chrysanthediacetate B and chrysanthediacetate C and β-dictyopterol, chrysandiol, chrysartemins A and B, and chlorochrymorin. [53, 54] Cnidium monnieri (Apiaceae) P6854/ Seeds Bitter principles: imperatorin, xanthotoxin, isopimpinellin, bergapten, osthole, and daucosterol [55] Croton tiglium (Euphorbiaceae) [56] Cyrtomium fortune (Dryopteridaceae)
P6856/ Seeds
P6859/ Rhizome
Phenolic compounds: 6'-methylglucuronide-5-hydroxy-chromone, ethyl α-D-glactopyranoside, neoechinulin A, 9,12,13-trihydroxyoctadeca-10(E),15(Z)-dienoic acid and phellopterin. [57] Dendrobium loddigesii (Orchidaceae) P6860/ Herb Alkaloids: dendrobine, nobiline, shihunidine, shihunine, moscatilin.
Phenolic compounds: Loddigesiinols G-J, crepidatuol B. [58] Dysosma versipellis (Berberidaceae)
P6862/ Rhizome
Lignans: podophyllotoxin Flavonoids: quercetin, maohuoside B, epimedin A, [59] Eclipta prostrata (Asteraceae) P6863/Herb Triterpenes, terthiophene, coumarins and isoflavone derivatives 5-Hydroxymethyl-(2,2':5' ,2'')-terthienyl tiglate, 5-hydroxymethyl-(2,2':5' ,2'')-terthienyl agelate, 5-hydroxymethyl-(2,2':5' ,2'')-terthienyl acetate, ecliptal, orobol, wedelolactone, demethylwedelolactone, isodemethylwedelolactone, alpha-formylterthienyl, strychnolactone, β-sitosterol, nonacosanol, stearic acid, lacceroic acid, 3,4-dihydoxy benzoic acid, eclalbasaponins II, I, III, XI and XII. [60, 61] Pharmacognosy Magazine, Volume 
β-sitosterol and tetratriacontane
Phenolic acids: Chlorogenic acid, 3,5-dicaffeoylquinic acid and caffeic acid. [63] Magnolia officinalis (Magnoliaceae) P6882/ Bark Tannins and flavonoids: gallic acid, sennosides A and B, hesperidin, naringin, rutin, syringin, magnolol and honokiol. [64] Mahonia bealei (Berberidaceae) P6883/ Wood Alkaloids: Berberine and other isoquinoline alkaloids [65] Mentha haplocalyx (Lamiaceae) P6884/ Herb Miscellaneous compounds: Triterpene saponins, flavonoids, rutin, tannins, monoterpenes (menthol). benzoic acid, trans-cinnamic acid, β-sitosterol, ursolic acid and daucosterol. [66, 67] Ophioglossum vulgatum (Ophioglossaceae)
-O-glycoside and ophioglonin [68] Polygonum cuspidatum (Polygonaceae)
P6894/ Rhizome
Anthraquinones: piceid, anthraglycoside A, anthraglycoside B, emodin, physcion, rhein, and chrysophanol.
Stilbenes: resveratrol and polydatin. [69, 70] Sanguisorba officinalis (Rosaceae)
P6901/ Rhizome
Hydrolysable and condensed tannins mostly derivatives of gallic and ellagic acids: methyl 4-O-β-D-glucopyranosy-5-hydroxy-3-methoxylbenzoate, 3,3' ,4'-tri-O-methylellagic acid, fisetinidol-(4α-8)-catechin, and (+)-catechin.
Flavonoids: rutoside, quercetin and kaempferol. [71] Scutellaria baicalensis (Lamiaceae) P6903/Wood Flavonoids, iridoid glucosides: baicalein, wogonin and oroxylin. [72] Senecio scandens (Asteraceae) P6905/ Herb Pyrrolizidine alkaloids, terpenoids: lupenone, oleanane, β-sitosterol, daucosterol, adonifoline, phydroxy benzeneacetic acid, 2-(1,4-dihydroxy-cyclohexanyl) -acetic acid, hyperoside, linarin. [73] Spatholobus suberectus (Fabaceae) P6907/Bark Flavonoids: 3' ,4' ,7-trihydroxyflavone, eriodictyol, plathymenin, dihydroquercetin, butin, neoisoliquiritigenin, dihydrokaempferol, liquiritigenin, and 6-methoxyeriodictyol. Ononin, pruneitin, gallocatechin, catechin, epicatechin, syringic acid, vanillic acid and daucosterol. [74] Taxillus chinensis (Loranthaceae) P6909/Herb Flavonoids: avicularin, quercetin, hyperin, d-catechol and quercitrin [75] all the tested doses as different variables. Cluster I included samples were the strongest CYP inhibitors. This cluster comprises Acacia catechu, Andrographis paniculata, Arctium lappa, Artemisia annua, Artemisia capillaris, Belamcanda chinensis, Bupleurum marginatum, Chrysanthemum indicum, Chrysanthemum morifolium, Polygonum cuspidatum, Sanguisorba officinalis, and Spatholobus suberectus. These samples mostly clustered in the right quadrant. Cluster II was also found in the same right quadrant exhibiting a moderate CYP inhibition (both the water and alcoholic extracts). The left side of the PCA plot contained all samples with an inhibition lower than approximately 50% at the lowest tested dose. They were subdivided into three main clusters (cluster III, IV, and V).
From the results displayed in Table 1 and Table 2 , and the multivariate analysis, it is obvious that the majority of secondary metabolites reported in both chemical abstracts and Medline for the corresponding bioactive extracts are phenolic secondary metabolites [ Figure 3 ]. These compounds were docked on CYP3A4 to validate the observed biological activity [ Table 3 ]. The results revealed that two flavonoids namely hesperidin and rutin were the most potent CYP3A4 inhibitors as evidenced from their high fitting scores and consequently, higher stability within the active sites as compared with the lead compound. The binding energies were Figure 4 ]. Thus, the formation of extra hydrogen bonds or ionic bonds (if the phenolic OH-groups is dissociated) with the amino acid residues at the active sites of the enzyme is responsible for the comparative firm binding of the two flavonoids with respect to the lead compound. This was revealed from the results of the molecular docking using the rulebased ionization mode [ Table 3 ] that examine the influence of ionization of various functional groups on its interaction at the binding site. 
DISCUSSION
The notable CYP3A4 inhibitory activity of many of the tested plants could be interpreted in virtue of their secondary metabolites mainly because of polyphenolic class of compounds. One of the underlying causes of this potent efficacy could be attributed to the formation of hydrogen and ionic bonds at the active sites of an enzyme due to the existence of several reactive phenolic OH groups. The phenolic hydroxyl groups can partly dissociate under physiological conditions resulting in O − ions interacting with positively charged amino groups, such as in arginine, lysine, and histidine. The charged and polar polyphenols interact with proteins by forming ionic bonds in addition to hydrogen bonds with several amino acids at the active site which might lead to enzyme inhibition and loss of function. [29] In the same context, extracts from the heartwood of A. catechu (Fabaceae) exhibited a potent CYP3A4 inhibition that could be attributed to the high contents of catechins and epicatechins (≈50% of the content) that were previously reported to inhibit CYP3A4. [30, 31] Additionally, the activity of A. catechu (Arecaceae) could be ascribed to their contents of tannins with their polyphenolic structures especially arecatannin A 1 -A 3 which are abundant in both extracts; as polyphenols they are able to bind the enzyme directly. Moreover, the alkaloid content with mainly arecoline (in the methanol extract) could contribute to the overall activity although this action has not been described for CYP3A4, but arecoline significantly inhibits other forms of cytochrome especially CYP1A1. [32] Besides, a plethora of secondary metabolites with exocyclic methylene groups as sesquiterpene lactones or reactive double or triple bonds can covalently bind to proteins with SH groups. These protein modification rather than the alcoholic extracts. Besides, the presence of lignans with a methylenedioxy group in an aromatic ring which are known CYP inhibitors [29] and saikosaponins, which showed a significant inhibition of both CYP1A2 and CYP3A4 may have significantly boosted the efficacy. [35] An additional representative empathizing on the difference between the potency of water and methanol extracts is M. bealei (Berberidaceae) where the alcoholic extract exerted higher inhibitory activity than the aqueous one. This notable activity could be explained in view of its richness of alkaloids as berberine which carries a methlenedioxy group-a known inhibitor of CYP1A1 and a substrate for the CYP2C9 and CYP2D6. [36, 37] However, the presence of few polyhydroxylated flavonoids could explain the moderate activity of the aqueous extract.
CONCLUSIONS
In this study, the effects of 57 widely used TCM plants on the key metabolizing enzyme CYP3A4 were assessed to understand the potential adverse effects that might occur by concomitant administration of many herbal preparations with other drugs. In addition, plant secondary metabolites can also inhibit or stimulate the expression of CYP genes. Since the aqueous extracts of many medicinal plants inhibit the activity of cytochrome p450 enzymes in vitro, as a consequence many adverse interactions can be expected. Furthermore, in vitro and in vivo studies are required on other cytochrome P450 isoforms to help patients who rely on phytomedicine beside other western medicine in treatment avoiding hazards that might be serious. greatly affect the three dimensional structure of proteins with inhibition of their activity and function. [29] A. paniculata and C. morifolium showed notable inhibition to CYP3A4 that could be due to the presence of certain sesquiterpenes with exocyclic methylene groups as andrographolide and chrysanthediol B, respectively that exerted reasonable fitting scores in the docking experiment with binding energy equals to -43.06 for the first and -23.63 kcal/mol for the latter in addition to the presence of several phenolic compounds in the tested extracts. The inhibitory potency of A. lappa (Asteraceae) is apparently due to its content of lignans, sesquiterpenes, polyacetylenes, and sulfur containing compounds, which are known inhibitors of many cytochromes. [33] The difference in B. marginatum extracts activity could be attributed to the presence of large quantities of flavonoids, mainly rutin, isoquercetrin, quercetin, and isorhamnetin. [34] However, the high solubility of these flavonoids, mainly rutin, in water explains the higher activity of water 
